Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

NCT: NCT06578156 · RECRUITING

NCT IDNCT06578156
StatusRECRUITING
Start Date2024-12-12
Completion2027-12-31
SponsorUniversity of Miami (OTHER)
First posted
Last updated

Brief Summary

This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑